Abstract:Background Granzyme activity can affect the processing and stability of miRNAs within target cells. They also could induce changes in miRNA expression that impact apoptotic signaling. Granzyme-induced apoptosis might result in changes to the miRNA profile, which can further influence the apoptosis and inflammation processes. Objective The aim of this study was to bioinformatically analyze which miRNAs and transcription factors bind to the CDS and UTR regions of the granzyme family to regulate gene expression in relation to granzyme evolution and their association with human cancer diseases. Methods The expression patterns of granzyme genes were analyzed in various human tissues. MiRNAs binding to the CDS and UTR of the granzyme family were examined, and the transcription factors binding to these miRNAs binding sites were also analyzed. Cytoscape program was used to visualize and analyze the networks of interactions between granzyme mRNA and miRNAs. Additionally, the evolutionary patterns of the granzyme family in relation to miRNAs and transcription factors binding were investigated. Results Analysis of the expression patterns of the granzyme family in various human tissues shows that GZMA and GZMK are strongly expressed in lymph nodes. GZMB exhibits strong expression in the bone marrow, while GZMA is prominently expressed in the spleen. Twenty-two miRNAs bind to both GZMK and GZMB mRNA, while six miRNAs bind to both GZMK and GZMM mRNA. The only miRNA that binds to GZMK, GZMB, GZMM, and GZMA mRNA is hsa-miR-146a-5p. Transcription factors JUND, FOS, and JUN are distinctly interconnected with has-miR-5696 and GZMK. Association data between the granzyme family and cancers showed that various miRNAs were consistently implicated and exhibited either upregulation or downregulation. Conclusion Although the granzyme family possesses distinct genetic information, it shows relatively high expression levels in the lymph node, spleen, and bone marrow. Many miRNAs specifically regulate granzyme gene expression, and various transcription factors are involved. Analyzing the granzyme genes-miRNAs-transcription factors-related network will provide crucial insights into the mechanisms of cancer development and suppression.

A Novel Nf-Kappa B Binding Site Controls Human Granzyme B Gene Transcription

Identification of Resting and Type I Ifn-Activated Human Nk Cell Mirnomes Reveals Microrna-378 and Microrna-30e As Negative Regulators of Nk Cell Cytotoxicity

Nf-Kappa B Regulates Bcl3 Transcription in T Lymphocytes Through an Intronic Enhancer

Distinct granzyme k expression in immune cells: a single-cell rna-seq meta-analysis

Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis

Comparison in the Effects of IL‐2, IL‐12, IL‐15 and IFN[alpha] on Gene Regulation of Granzymes of Human NK Cell Line NK‐92

GW24-e3853 Identification of Novel Pre-translational Regulatory Mechanisms for NF-kB Activation

Abstract 568: Identification of Novel Pre-translational Regulatory Mechanisms for NF-?B Activation

Identification of Novel Pretranslational Regulatory Mechanisms for NF-κB Activation.

Functional Characterization of the NF-κB Binding Site in the Human NOD2 Promoter

Massive GGAAs in Genomic Repetitive Sequences Serve As a Nuclear Reservoir of NF-κB.

Identification Of Novel Nf-Kappa B Transcriptional Targets In Tnf Alpha-Treated Hela And Hepg2 Cells

Subset Of Genes Targeted By Transcription Factor Nf-Kappa B In Tnf Alpha-Stimulated Human Hela Cells

Structural basis for proteolytic specificity of the human apoptosis-inducing granzyme M.

Ectopic Expression of Active Granzyme B Gene Leads to Multinuclear Giant Cels

Granzyme mRNA-miRNA interaction and its implication to functional impact

Identification of Serpinb1 As A Physiological Inhibitor of Human Granzyme H

Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment

Characterization of Genome-Wide Binding of NF-κB in TNFα-stimulated HeLa Cells.

Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation

TGF-β1 expression in regulatory NK1.1-CD4+NKG2D+ T cells dependents on the PI3K-p85α/JNK, NF-κB and STAT3 pathways